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Abstract 
Introduction: Pure gall bladder squamous cell cancer comprises less than 1% of all gallbladder 
malignancies and prominent, well differentiated keratinization is a key histological feature. 
Presentation of Case: This is a case report of an elderly male who presented with nausea and weight 
loss. His physical examination revealed significant hepatomegaly without jaundice. A CT scan of the 
abdomen revealed a large infiltrated mass in the liver with significant regional and distal enlarge lymph 
nodes. In comparison to a CT scan done 17 months ago - showing a normal gall bladder and liver - it was 
determined that this mass was likely gall bladder cancer with direct invasion into the liver. Histology via 
percutaneous biopsy showed pure squamous cell carcinoma, by evidence of prominent and well 
differentiated keratinization. He was staged as IIIb (T3N1M0) deeming the cancer unresectable with a 
poor prognosis.  
Conclusion: Gall bladder cancer remains an uncommon cancer of a variety of histological types, in 
which pure squamous cell dysplasia is rare. This type of cancer is more aggressive than most other 
histological types and as a result is rapidly progressing, with a poor prognosis. 
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Introduction 
 Gallbladder cancer is a rare and aggressive tumor that is commonly associated with a poor 
prognosis. Patients present with nonspecific symptoms and signs leading to an often incidental and 
late diagnosis. Pure gall bladder squamous cell cancer comprises of less than 1% of all gallbladder 
malignancies and prominent, well differentiated keratinization is a key histological feature. We present 
a case of an elderly male with initial symptoms of nausea and weight loss, who was later found to have 
stage IIIB (T3N1M0) pure squamous cell gall bladder – developed within 17 months of last known 
normal imaging. 
Case Report 
 We present an 88 year old African American male with a past medical history of 
hypertension and benign prostatic hypertrophy, who presented to the emergency department with a 
three day history of nausea without vomiting. This nausea was not affected by meals but was 
associated with early satiety and decreased appetite. He also reporteda subjectiveweight loss. Areview 
of symptoms was negative for abdominal pain or jaundice. He had no history of symptomatic 
gallstones. He smoked 1 cigarette weekly and occasionally drank alcohol.  
His vitals were blood pressure 150/66 mmHg, pulse rate 72 beats/min, respiratory rate 18, 
andtemperature 36.5oC with oxygen saturation 98% on room air.  A physical examination was 
significant for a firm, smooth, non-tender right upper quadrant mass extending across the midline 
which was assessed as hepatomegaly. The patient was anicteric. Other systems were normal. 
Initial lab investigations on admission showed normocytic anemia (hemoglobin 8.3 g/dL, 
mean corpuscular volume 85 fl) with mild leukocytosis (white blood cell count 13300/uL) without 
bands and thrombocytosis (platelets 522 k/UL). Complete metabolic profile did not show evidence of 
significant cholestasis (total bilirubin 1.1, alkaline phosphatase 123) with other liver function tests 
within normal limits.  
A CT scan of the abdomen and pelvis with contrast revealed a large heterogeneous infiltrative 
mass in the liver in segments 5, 8, 4a and 4b with additional satellite nodules. There were multiple foci 
of air within the lesion as it abutted the distal stomach and the C-loop of the duodenum with mass 
effect. The gallbladder was not visualized. Pathological lymph nodes were noted anterior to the distal 
thoracic esophagus, anterior-superior to the pancreatic neck in the gastro-hepatic ligament region, 
superior to the left renal vessels and in the portocaval region. CA 19-9, alfa fetoprotein, and CA 125 
were within normal limits. 17 months ago, an abdominal CT done for investigation of a different 
presentation showed normal liver and gallbladder, with multiple asymptomatic gallstones. On 
comparison of both of the images it was determined that this new aggressive lesion was likely gall 
bladder cancer directly invading the liver. Four core needle biopsies were taken from the liver, with 
subsequent histopathology showing a moderately differentiated, keratinizing squamous cell carcinoma. 
A staging CT of the chest showed para-esophageal nodes suspicious for metastatic disease as well as a 
4 mm ground-glass nodule in the right upper lobe.  
The patient was staged at IIIb (T3N1M0) which deemed the tumor inoperable. As his 
prognosis was poor, palliative care was instituted. He was subsequently discharged to a hospice care 
facility. 
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Discussion 
Cancers of the gallbladder are an uncommon occurrence, with an incidence of 1-2.5 cased per 
100,000 [1]. Adenocarcinoma is the most common, making up about 95% of gallbladder cancers [2]. 
Pure squamous cell carcinoma (GCSCC) is very rare, with a frequency of ≤1%  [2]. Cholelithiasis has 
the strongest association to date, being present in up to 85% of cases [1,5]. Larger stones (>1cm) also 
increases the risk [3]. However the overall incidence of gallbladder cancer in patients with 
cholelithiasis is 0.2-3% [4,5]. With this low incidence therefore, prophylactic cholecystectomy in 
asymptomatic patients with cholelithiasis, without remarkable gallbladder changes (e.g. porcelain gall 
bladder) would be impractical.  
The presentation of gall bladder cancer is variable, with non-specific but alarming signs; such 
as nausea, vomiting and weight loss. Incidental findings in patients with symptomatic gallstones are 
also common [1]. Symptoms and signs of obstructive jaundice were once the common clues to 
diagnosis [6]. However, as imaging became more available and frequently used, these presentations 
are becoming less common, and are indicative of a later stage and hence a poorer prognosis. These 
more telling symptoms and signs were not present in our patient. Therefore, it was only with the 
presence of the concerning CT scan findings (Fig. 1) that gall bladder cancer was entertained as a 
differential. In retrospect, it is also probable that the hepatomegaly felt on physical examination was 
that of a palpable gallbladder, as liver enlargement was not evident on imaging. More available and 
frequent imaging has also increased pre-operative diagnosis, which has currently occurred in 30% of 
cases [5] – our case being one of them (Fig. 1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 CT scan showing large heterogeneous mass (red arrow) in the liver (A), without 
distinct visualization of gall bladder, compared to CT scan taken 17 months ago (B) with normal 
appearing gallbladder (yellow arrow) 
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One characteristic histological feature of squamous cell carcinoma is prominent and well 
differentiated keratinization [2] (Fig. 2), which differentiates it from the focal and ill-defined 
keratinization typical of adenosquamous carcinoma [2]. GBSCC is also stated to be more aggressive 
than most other types [2,7,8], and was proven to be so in our patient, as prior imaging taken 17 months 
before showed a normal appearing gallbladder.  
 
 
 
Figure 2 Histology showing pure squamous cell carcinoma (GCSCC) by evidence of prominent, well-
differentiated keratinization (blue arrow in A, also seen in B) 
 
Currently, histology does not play a major role in treatment or prognosis, as these are 
determined by cancer resectability, local infiltration and evidence of metastasis [5]. As most of gall 
bladder cancers are at an advanced stage at diagnosis, prognosis is generally poor. Our patient’s stage 
at diagnosis was advanced (Stage IIIb/T3N1M0), making his tumor unresectable. In such cases 
palliative chemotherapy is optional and this was offered to our patient. 
Conclusion 
Gall bladder cancer remains an uncommon cancer of a variety histological types, in which 
pure squamous cell dysplasia is rare. This type of cancer is defined by the presence of prominent 
keratinization, differentiating it from mixed histological types. This type of cancer is more aggressive 
than most other histological types and as a result is rapidly progressing, with a poor prognosis.   
Consent Statement 
 We confirmed that the patient has given informed consent to the publishing of this case. 
References 
1. Shaffer EA. Gallbladder cancer: the basics. Gastroenterology &hepatology. 2008,4(10):737-741 
2. Roa JC, TapiaO, Cakir A, Basturk O et al. Squamous cell and adenosquamous carcinomas of the 
gallbladder: Clinicopathological analysis of 34 cases identified in 606 carcinomas. Modern 
Pathology. 2011, 24(8:1069-1078 
  
 
Kennedy R et al. American Journal of Cancer Case Reports               2020, 8:6-10                                        Page 5 of 5 
Ivy Union Publishing | http: //www.ivyunion.org                                    January 10, 2020 | Volume 8, Issue 1  
 
3. Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. Lancet Oncology. 
2003, 4(3:167-176 
4. Muszynska C, Lundgren L, Lindell G, Andersson R, Nilsson J, Sandström P, &Andersson B. 
Predictors of incidental gallbladder cancer in patients undergoing cholecystectomy for benign 
gallbladder disease: Results from a population-based gallstone surgery registry. Surgery.2017, 
162(2:256-263 
5. Goetze T O. Gallbladder carcinoma: Prognostic factors and therapeutic options. World Journal of 
Gastroenterology.2015, 21(43):12211-12217 
6. Piehler JM. Primary Carcinoma of the Gallbladder. Archives of Surgery.1977, 112(1):26 
7. Mghirbi F, Ayadi M, Karray W, et al. Squamous cell carcinoma of the gallbladder. Translational 
Gastroenterology and Hepatology.2016, 1:78-78 
8. Kalayarasan R, Javed A, Sakhuja P, &Agarwal AK. Squamous variant of gallbladder cancer: Is it 
different from adenocarcinoma? The American Journal of Surgery. 2013, 206(3):380-385 
 
